Fluxion Biosciences, Inc.
Fluxion Biosciences, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development of advanced microfluidic systems for life sciences research and diagnostics. With a focus on single-cell analysis and high-throughput screening, Fluxion's innovative platforms enable researchers to gain deeper insights into cellular behaviour and disease mechanisms. The company’s flagship products, including the IsoFlux System and the BioFlux platform, are distinguished by their ability to provide precise, real-time data, setting them apart in a competitive market. Fluxion's commitment to advancing scientific discovery has garnered recognition within the industry, positioning it as a trusted partner for academic and commercial laboratories alike. With a strong emphasis on innovation and quality, Fluxion Biosciences continues to drive progress in the fields of genomics and personalised medicine.
DitchCarbon Score
How does Fluxion Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fluxion Biosciences, Inc.'s score of 18 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fluxion Biosciences, Inc.'s reported carbon emissions
Fluxion Biosciences, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete emissions figures or defined initiatives, it is challenging to assess their environmental impact or sustainability efforts. However, as a company operating in the biosciences sector, Fluxion may be expected to align with industry standards for reducing carbon footprints and addressing climate change. Further information on their climate commitments or future initiatives would be necessary to provide a comprehensive overview of their environmental strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fluxion Biosciences, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
